1. Preclinical Efficacy of Anti-RON Antibody–Drug Conjugate Zt/g4-MMAE for Targeted Therapy of Pancreatic Cancer Overexpressing RON Receptor Tyrosine Kinase
   Hang-Ping Yao et al, 2018, Molecular Pharmaceutics CrossRef
2. Vitamin D3-dependent VDR signaling delays ron-mediated breast tumorigenesis through suppression of β-catenin activity
   Abby L. Johnson et al, 2015, Oncotarget CrossRef
3. Roles of c-Met and RON kinases in tumor progression and their potential as therapeutic targets
   Katherine Chang et al, 2015, Oncotarget CrossRef